BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 14, 1998
View Archived Issues
Micrologix Biotech advances development of antimicrobial peptides for treatment of eye infections
Read More
New anticonvulsant option now available in U.K.
Read More
Synthelabo compounds act as 5-HT receptor ligands
Read More
Glaxo Wellcome receives first marketing approval for new asthma therapeutic
Read More
Heart valve abnormalities a problem among appetite suppressant-treated obese patients
Read More
Inhibitors of sPLA2 claimed by Lilly for septic shock, etc.
Read More
Preparation and use of peptide bradykinin B2 receptor agonists described by Fournier
Read More
Antiplatelet compounds developed by Merck & Co.
Read More
Inhibitors of ICE activity described by Vertex
Read More
Orally active anticoagulants in early development at Gedeon Richter
Read More
Antisense oligodeoxynucleotide to rat ICAM-1 tested in rat model of enterocolitis
Read More
Neuroprotective effects of S-12024-2 demonstrated in rat model of neurodegeneration
Read More
Japanese researchers report progress in the gene therapy of gastric cancer
Read More
Antiasthma drug can be used safely in combination with anticonvulsants
Read More
Role of oral porcine spasmolytic polypeptide in GI disorders studied by Danish group
Read More
Roche to withdraw support for development of Kyowa Hakko's antiparkinsonian
Read More
Nateglinide preclinical and clinical data featured at diabetes meeting
Read More
Phase II trial of revolutionary migraine treatment completed ahead of schedule
Read More
Celgene successfully completes phase I multiple-dose trial of lead SelCID compound
Read More
Company Profile: Xcyte Therapies
Read More
FDA approves, HMR begins shipping new treatment for adult rheumatoid arthritis
Read More
Development of MGDF discontinued at Amgen
Read More
Phase II testing of ISV-205 begins for glaucoma
Read More
Early clinical trial results reported for cilansetron at recent congress
Read More
AEterna releases interim phase I/II data for Psovascar
Read More
Licensing opportunity from RCT: use of cobalamins to control excess nitric oxide
Read More
Lodensine cleared for phase II trials in HIV patients
Read More
